Thromb Haemost 1983; 50(02): 541-542
DOI: 10.1055/s-0038-1665250
Original Article
Schattauer GmbH Stuttgart

Plasma Fibrinopeptide A and Beta-Thromboglobulin in Patients with Chest Pain

J T Douglas
The University Department of Medicine, Royal Infirmary, Glasgow, U. K.
,
G D O Lowe
The University Department of Medicine, Royal Infirmary, Glasgow, U. K.
,
C D Forbes
The University Department of Medicine, Royal Infirmary, Glasgow, U. K.
,
C R M Prentice
The University Department of Medicine, Royal Infirmary, Glasgow, U. K.
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 21. Januar 1983

Accepted 24. Mai 1983

Publikationsdatum:
18. Juli 2018 (online)

Preview

Summary

Plasma levels of β-thromboglobulin (BTG) and fibrinopeptide A (FPA), markers of platelet release and thrombin generation respectively, were measured in 48 patients within 3 days of admission to hospital for acute chest pain. Twenty-one patients had a confirmed myocardial infarction (MI); 15 had unstable angina without infarction; and 12 had chest pain due to noncardiac causes. FPA and BTG were also measured in 23 control hospital patients of similar age. Mean plasma BTG levels were not significantly different in the 4 groups. Mean plasma FPA levels were significantly higher in all 3 groups with acute chest pain when compared to the control subjects (p < 0.01), but there were no significant differences between the 3 groups. Increased FPA levels in patients with acute chest pain are not specific for myocardial infarction, nor for ischaemic chest pain.